<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73786">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01798043</url>
  </required_header>
  <id_info>
    <org_study_id>CR-12-048-CH-LV</org_study_id>
    <nct_id>NCT01798043</nct_id>
  </id_info>
  <brief_title>Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance</brief_title>
  <official_title>Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to use cardiac MRI scans and analysis techniques to evaluate differences in
      cardiac function after 12 months of pacing in patients with pacing leads placed in different
      positions within the right ventricle (apically or septally).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change in LV chamber volumes.</measure>
    <time_frame>12 months (baseline to end of study)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Dyssynchrony</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ejection fraction</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Strain rate</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Heart Block</condition>
  <condition>Sick Sinus Syndrome</condition>
  <condition>Atrioventricular Block</condition>
  <condition>Ventricular Dysfunction</condition>
  <arm_group>
    <arm_group_label>Septal RV lead with &gt;50% pacing</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Septal RV lead with  &lt;50% pacing</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Apical RV lead with &gt;50% pacing</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Apical RV lead with &lt;50% pacing</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients previously implanted with a pacemaker system not contraindicated for use in an
        MRI scanner.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have been implanted with an Accent MRI pacemaker and Tendril MRI leads.

          -  Have an RV lead implanted apically (group A) or septally (Group B)

          -  Are RV paced for &lt;50% of the time (groups A2 and B2)

          -  Are RV paced for &gt; 50% of the time (Groups A1 and B1)

          -  Are â‰¥ 18 years of age.

          -  Are able to provide written informed consent.

          -  Are willing and able to comply with the prescribed follow-up tests and schedule of
             evaluations.

        Exclusion Criteria:

          -  Have permanent atrial fibrillation with preserved intrinsic conduction

          -  Have a non-MRI compatible device or material implant (e.g., intracranial aneurysm
             clip, non-MRI compatible devices or material, metals or alloys, etc.).

          -  Have a lead extender, plug or adaptor.

          -  Do not have an RV lead implanted apically or septally.

          -  Are eligible for groups A1 or B1 but appropriate group already has 20 patients
             enrolled.

          -  Are eligible for groups A2 or B2 but appropriate group already has 5 patients
             enrolled

          -  Are currently participating in another device or drug investigation which includes an
             active treatment arm.

          -  Are pregnant or planning to become pregnant during the duration of the study.

          -  Have a life expectancy of less than 12 months from Screening due to any
             life-threatening condition.

          -  Are contraindicated for an MRI scan due to any other reason.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rainer Zbinden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Triemli Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marcus Simon</last_name>
    <phone>+32 277 46758</phone>
    <email>msimon@sjm.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stadtspital Triemli</name>
      <address>
        <city>Zurich</city>
        <zip>8063</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Zbinden, MD</last_name>
      <phone>044 466 1314</phone>
      <email>rainer.zbinden@triemli.zuerich.ch</email>
    </contact>
    <investigator>
      <last_name>Rainer Zbinden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 14, 2013</lastchanged_date>
  <firstreceived_date>February 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrioventricular Block</mesh_term>
    <mesh_term>Heart Block</mesh_term>
    <mesh_term>Sick Sinus Syndrome</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
